Login / Signup

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.

Sukrit SrivastavaSonia VermaMohit KamthaniaRupinder KaurRuchi Kiran BadyalAjay Kumar SaxenaHo-Joon ShinMichael KolbeKailash C Pandey
Published in: JMIR bioinformatics and biotechnology (2020)
The present study is highly significant in terms of the molecular design of prospective CTL and HTL vaccines against SARS-CoV-2 infection with potential to elicit cellular and humoral immune responses. The epitopes of the designed MEVs are predicted to cover the large human population worldwide (96.10%). Hence, both designed MEVs could be tried in vivo as potential vaccine candidates against SARS-CoV-2.
Keyphrases